Hims & Hers Health is set to have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to ...

A controversial Super Bowl ad by Hims & Hers targets America's obesity epidemic and criticizes the healthcare system. The ad ...

The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...

The Africa Centres for Disease Control and Prevention (Africa CDC) and African Union Development Agency - New Partnership for Africa's Development (AUDA-NEPAD) are proud to announce the signing of a ...

Sanofi in partnership with Regeneron to present 24 abstracts across approved and investigational medicines at AAAAI Annual Meeting in San Diego: Paris Friday, February 7, 2025, 12 ...

George Medicines appoints Amy Carroll as Senior Vice President of Medical AffairsLondon, UK, 3 February 2025 – George Medicines, a late-stage ...

The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...

Online sellers of knockoff GLP-1 drugs have seized on shortages as an opportunity to advertise a more steady, lower-cost supply of the products compared to branded versions. One such company, Hims & ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

The government of the People's Republic of China and the government of the Kingdom of Thailand on Saturday issued a joint ...